LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
| dc.contributor.author | Perreault, Sebastien | |
| dc.contributor.author | Spano, Jean-Philippine | |
| dc.contributor.author | Nilsson, Anna | |
| dc.contributor.author | Deyell, Rebecca J. | |
| dc.contributor.author | Doz, Francois | |
| dc.contributor.author | Geoerger, Birgit | |
| dc.contributor.author | Gümüş, Mahmut | |
| dc.date.accessioned | 2025-05-10T19:38:43Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description | 29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) -- NOV 21-24, 2024 -- Houston, TX | |
| dc.description.abstract | [No abstract available] | |
| dc.description.sponsorship | Soc Neuro Oncol | |
| dc.identifier.doi | 10.1093/neuonc/noae165.0375 | |
| dc.identifier.issn | 1522-8517 | |
| dc.identifier.issn | 1523-5866 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1093/neuonc/noae165.0375 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/9452 | |
| dc.identifier.volume | 26 | |
| dc.identifier.wos | WOS:001362632500032 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Oxford Univ Press Inc | |
| dc.relation.ispartof | Neuro-Oncology | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.title | LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS | |
| dc.type | Conference Object |
Dosyalar
Orijinal paket
1 - 1 / 1










